Intratumoral heterogeneity of ERBB2/HER2 expression in micropapillary urothelial carcinoma.
Sumit Isharwal(Memorial Sloan Kettering Cancer Center), Hikmat Al‐Ahmadie(Unknown), Victor E. Reuter(Memorial Sloan Kettering Cancer Center), Guido Dalbagni(Memorial Sloan Kettering Cancer Center), Samson W. Fine(Memorial Sloan Kettering Cancer Center), François Audenet(Université Paris Cité), Satish K. Tickoo(Unknown), S. Machele Donat(Memorial Sloan Kettering Cancer Center), Gouri J. Nanjangud(Memorial Sloan Kettering Cancer Center), Jonathan E. Rosenberg(Memorial Sloan Kettering Cancer Center), Dean F. Bajorin(Memorial Sloan Kettering Cancer Center), Gopa Iyer(Memorial Sloan Kettering Cancer Center), Bernard H. Bochner(Memorial Sloan Kettering Cancer Center), David B. Solit(Memorial Sloan Kettering Cancer Center), Harry W. Herr(Memorial Sloan Kettering Cancer Center), Ying‐Bei Chen(Memorial Sloan Kettering Cancer Center), Hongying Huang, Anuradha Gopalan(Memorial Sloan Kettering Cancer Center)
Cited by 1
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k